blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3849599

EP3849599 - PNEUMOCOCCAL FUSION PROTEIN VACCINES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.06.2021
Database last updated on 22.08.2024
FormerThe international publication has been made
Status updated on  21.03.2020
Most recent event   Tooltip27.09.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
The Children's Medical Center Corporation
55 Shattuck Street
Boston, Massachusetts 02115 / US
[2021/29]
Inventor(s)01 / MALLEY, Richard
15 Bayview Avenue
Beverly, Massachusetts 01915 / US
02 / LU, Yingjie
188 Corey St. West
Roxbury, Massachusetts 02132 / US
03 / ZHANG, Fan
188 Corey St. West
Roxbury, Massachusetts 02132 / US
 [2021/29]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2021/29]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date19860907.512.09.2019
[2021/29]
WO2019US50800
Priority number, dateUS201862730199P12.09.2018         Original published format: US 201862730199 P
[2021/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020056127
Date:19.03.2020
Language:EN
[2020/12]
Type: A1 Application with search report 
No.:EP3849599
Date:21.07.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 19.03.2020 takes the place of the publication of the European patent application.
[2021/29]
Search report(s)International search report - published on:US19.03.2020
(Supplementary) European search report - dispatched on:EP30.05.2022
ClassificationIPC:A61K39/09, A61K39/116
[2021/29]
CPC:
C12N15/62 (EP,IL); C07K14/3156 (EP,IL,KR,US); C07K14/47 (IL,US);
A61K39/092 (EP,IL,KR); A61P31/04 (KR); A61K2039/6031 (EP,IL,KR);
A61K2039/627 (EP,IL,KR); A61K2039/70 (EP,IL,KR); C07K2319/00 (IL,US);
C07K2319/20 (EP,IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/29]
TitleGerman:PNEUMOKOKKEN-FUSIONSPROTEINIMPFSTOFFE[2021/29]
English:PNEUMOCOCCAL FUSION PROTEIN VACCINES[2021/29]
French:VACCINS À PROTÉINES DE FUSION PNEUMOCOCCIQUES[2021/29]
Entry into regional phase31.03.2021National basic fee paid 
31.03.2021Search fee paid 
31.03.2021Designation fee(s) paid 
31.03.2021Examination fee paid 
Examination procedure31.03.2021Examination requested  [2021/29]
30.01.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
31.03.2021Renewal fee patent year 03
27.09.2022Renewal fee patent year 04
27.09.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2014124228  (CHILDRENS MEDICAL CENTER [US]);
 [E]EP3849587  (AFFINIVAX INC [US]);
International search[A]WO2014018904  (GENOCEA BIOSCIENCES INC [US], et al);
 [XY]US2015374811  (MALLEY RICHARD [US], et al);
 [Y]US2016090404  (MALLEY RICHARD [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.